Aventis sniffing out trouble
Executive Summary
Aventis is building a promotional campaign for Allegra around Schering-Plough's corporate-wide good manufacturing compliance difficulties. Aventis issued a press release March 14 declaring that it is "increasing production" of Allegra "to assure both patients and physicians that there will be an ample supply" for the spring allergy season. Aventis added that it is "taking steps to make increased supplies" of Nasacort AQ available, and that it is "prepared with substantial supplies of Azmacort." Schering-Plough says its supplies of Claritin are sufficient for the spring allergy season (1"The Pink Sheet" March 5, p. 6)